Powars et al developed criteria for staging patients with chronic lung disease secondary to sickling hemoglobinopathies. The authors are from the University of Southern California in Los Angeles.
Parameters:
(1) clinical findings
(2) arterial blood gas findings
(3) chest X-ray findings
(4) pulmonary function tests (FEV1, TLC, FVC, FEV1 to FVC ratio)
(5) cardiac changes on ECG and echocardiography
(6) pressure in the pulmonary artery
Parameter |
Stage 1 |
Stage 2 |
clinical findings |
chronic cough; recurrent substernal chest pain |
moderate chest pain |
arterial blood gases |
normal oxygen saturation |
normal oxygen saturation |
chest X-ray |
changes suggestive of increased interstitial markings; hyperexpansion; decreased distal pulmonary vascularity |
diffuse, fine interstitial fibrosis in all lobes |
pulmonary function |
mild decrease, at 80% of predicted |
moderate decrease at 60% of predicted |
ECG and Echocardiography |
left ventricular preponderance |
balanced ventricular hypertrophy |
pulmonary artery pressure |
normal |
normal |
Parameter |
Stage 3 |
Stage 4 |
clinical findings |
severe midline chest pain ("crushing") |
severe and prolonged chest pain |
arterial blood gases |
mild to moderate hypoxia (PaO2 70 mm Hg while stable) |
severe hypoxia (PaO2 60 mm Hg while stable) |
chest X-ray |
pulmonary fibrosis |
severe pulmonary fibrosis |
pulmonary function |
severe decrease, at 40% of predicted |
marked decrease; patient unable to perform testing; dyspnea at rest |
ECG and Echocardiography |
right ventricular hypertrophy and right atrial dilation |
severe right ventricular and right atrial hypertrophy' cor pulmonale |
pulmonary artery pressure |
borderline elevation or high normal |
pulmonary hypertension |
Specialty: Pulmonology, Genetics, Hematology Oncology
ICD-10: ,